Skip to main content

Table 2 Final diagnosis for the additional lesions as assessed by reference standards

From: Contrast-enhanced mammography (CEM) versus MRI for breast cancer staging: detection of additional malignant lesions not seen on conventional imaging

Additional lesions (n = 41)

Number (%)

Benign lesions

35 (85%)

 Non-specific benign findingsa

28

 Fibroadenoma

4

 Benign intramammary lymph node

2

 ADH

1

Malignant lesions

6 (15%)

 Side

  Right

6

Location of additional malignant lesion relative to index malignant lesion(s)

  Same breast same quadrantb

3

  Same breast different quadrantc

3

Pathological features

  Invasive breast cancer

3

   IDC

1

   IDC and DCIS

1

   IDC and ILC with DCIS

1

Histopathological Features

  Grade 2

3

  Luminal A

2

  Luminal B

1

Malignant intramammary lymph node

1

  DCIS only

2

   High grade

1

   Low grade

1

  1. aSurgical or core biopsy pathology was available for 19 lesions; the remaining nine lesions were stable on follow-up for a minimum of 12 months. bTwo invasive malignancies, one DCIS. cOne invasive malignancy, one DCIS, one metastatic intramammary lymph node. ADH Atypical ductal hyperplasia, DCIS Ductal carcinoma in situ, ER Oestrogen receptor, HER2/Neu Human epidermal growth factor receptor 2, IDC Invasive duct carcinoma, ILC Invasive lobular carcinoma